Masayuki Sho Selected Research

Neoplasms (Cancer)

12/2023	Impact of tumor shrinkage pattern with biweekly triplet gemcitabine+cisplatin+S-1 regimen for biliary tract cancers: Implications for neoadjuvant therapy from the data of KHBO1401 (KHBO1401-1A study).
12/2023	Combination of carbohydrate antigen 19-9 level and tumor size after neoadjuvant chemoradiation therapy may predict early recurrence of resectable pancreatic ductal adenocarcinoma.
12/2023	Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis.
11/2023	Identification of Nectin Family Interactive Gene Panel and Stratification of Clinical Outcomes in Patients with Pancreatic Cancer.
5/2023	Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma.
4/2023	Liver metastases of a neuroendocrine tumor arising from a tailgut cyst treated with interventional locoregional therapies: a case report and review of the literature on recurrent cases.
2/2023	Comparison of infectious complications after spleen preservation versus splenectomy during laparoscopic distal pancreatectomy for benign or low-grade malignant pancreatic tumors: A multicenter, propensity score-matched analysis.
1/2023	Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study.
12/2022	Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models.
11/2022	Imaging features of β-catenin-activated hepatocellular adenoma with weak β-catenin activation: A rare case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Sho Research Topics

Disease

64	Neoplasms (Cancer) 12/2023 - 04/2003
46	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 04/2003
31	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2009
26	Adenocarcinoma 12/2023 - 11/2014
12	Stomach Neoplasms (Stomach Cancer) 02/2024 - 07/2010
10	Pancreatic Fistula (Pancreatic Fistulas) 01/2022 - 02/2013
9	Lymphatic Metastasis 01/2022 - 06/2015
8	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 04/2005
7	Inflammation (Inflammations) 10/2022 - 08/2003
6	Hemorrhage 10/2023 - 12/2017
6	Reperfusion Injury 11/2019 - 05/2005
5	Adenoma (Adenomas) 01/2022 - 03/2015
5	Disease Progression 01/2022 - 04/2010
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 11/2010
4	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2015
3	Rectal Neoplasms (Rectal Cancer) 11/2023 - 01/2018
3	Surgical Wound Infection 01/2023 - 04/2016
3	Polyps 10/2022 - 03/2015
3	Esophageal Squamous Cell Carcinoma 05/2022 - 03/2014
3	Non-alcoholic Fatty Liver Disease 04/2022 - 03/2014
3	Pneumonia (Pneumonitis) 01/2022 - 12/2005
3	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 06/2024 - 04/2021
2	Hypoxia (Hypoxemia) 02/2024 - 04/2023
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2023 - 01/2023
2	Sarcopenia 11/2023 - 12/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 01/2011
2	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 07/2019
2	Renal Insufficiency (Renal Failure) 01/2021 - 11/2015
2	Body Weight (Weight, Body) 01/2021 - 11/2018
2	Carcinoma (Carcinomatosis) 10/2020 - 09/2015
2	Residual Neoplasm 02/2019 - 11/2010
2	Fatigue 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

18	Gemcitabine FDA Link 12/2023 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 03/2023 - 06/2016
9	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2013
7	AntigensIBA 12/2023 - 04/2010
7	Fluorouracil (Carac)FDA LinkGeneric 09/2020 - 11/2009
6	CarbohydratesIBA 12/2023 - 02/2019
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 05/2020 - 04/2003
5	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 01/2017
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 01/2013
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2016
5	Small Interfering RNA (siRNA)IBA 09/2020 - 04/2010
4	Member 14 Tumor Necrosis Factor ReceptorsIBA 11/2019 - 03/2014
3	EnzymesIBA 04/2022 - 03/2014
3	CytokinesIBA 01/2020 - 08/2003
3	degradable starch microspheresIBA 03/2017 - 01/2013
3	PowdersIBA 03/2017 - 01/2013
3	LigandsIBA 02/2009 - 04/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 04/2023
2	Therapeutic UsesIBA 10/2023 - 01/2011
2	C-Reactive ProteinIBA 01/2023 - 11/2018
2	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2020
2	InterferonsIBA 10/2022 - 05/2013
2	Hemoglobins (Hemoglobin)IBA 09/2022 - 08/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 01/2013
2	Alanine Transaminase (SGPT)IBA 04/2022 - 01/2013
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 04/2003
2	Carcinoembryonic AntigenIBA 09/2021 - 11/2018
2	Serum AlbuminIBA 01/2021 - 11/2018
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 01/2013
2	tegafur-gimeracil-oteracilIBA 10/2020 - 12/2017
2	Docetaxel (Taxotere)FDA Link 09/2020 - 10/2017
2	Claudin-4IBA 11/2019 - 03/2019
2	von Willebrand FactorIBA 11/2019 - 01/2018
2	folfirinoxIBA 11/2019 - 01/2019
2	N-acetyltalosaminuronic acid (NAT)IBA 06/2019 - 07/2015
2	Fibrinogen (Factor I)FDA Link 04/2019 - 01/2017
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Monoclonal AntibodiesIBA 01/2011 - 04/2007

Therapy/Procedure

34	Drug Therapy (Chemotherapy) 06/2024 - 04/2009
25	Neoadjuvant Therapy 01/2024 - 11/2011
21	Pancreaticoduodenectomy 08/2023 - 11/2009
20	Therapeutics 10/2023 - 12/2005
16	Pancreatectomy 12/2023 - 04/2012
10	Adjuvant Chemotherapy 06/2024 - 11/2009
7	Operative Surgical Procedures 06/2024 - 03/2014
6	Length of Stay 06/2024 - 02/2013
6	Esophagectomy 04/2024 - 11/2018
6	Hepatectomy 12/2023 - 11/2019
6	Gastrectomy 09/2022 - 07/2010
4	Splenectomy 02/2023 - 03/2013
4	Combination Drug Therapy (Combination Chemotherapy) 09/2020 - 11/2009
3	Stents 01/2023 - 02/2019
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 06/2018
3	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2016
3	Chemoradiotherapy 01/2021 - 11/2011
3	Pancreaticojejunostomy 07/2020 - 01/2016
3	Radiotherapy 06/2019 - 11/2010
3	Ligation 02/2019 - 08/2003
3	Operative Time 01/2018 - 01/2017
3	Combined Modality Therapy 11/2016 - 11/2010
2	Immunotherapy 05/2022 - 04/2005
2	Sutures (Suture) 05/2022 - 04/2021
2	Colectomy 01/2022 - 11/2010
2	Microspheres (Microsphere) 08/2019 - 03/2017
2	Catheters 06/2016 - 11/2011
2	Vascular Access Devices (Arterial Line) 06/2016 - 06/2012